13
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Production and Characterization of High Affinity Monoclonal Antibodies to Cyclic Anti-Depressant Molecules

, &
Pages 527-538 | Published online: 25 Sep 2008

References

  • Engvall E., Ruoslahti K. Principles of KLISA and recent applications to the study of molecular interactions. Immunoaasays in the Clinical Laboratory, R. K. Nakamura, W. R. Ditto, K. S. Tucker, III. Alan R. Liss, Inc., New York 1978; 89–99
  • Oi V. T., Herzenberg L. A. Immunoglobulin producing hybrid cell lines. Selected Methods in Cellular Immunology, B. B. Mishell, S. M. Shiigi. W.R. Freeman, San Francisco 1980; 125–146
  • Scatchard G. The attractions of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 1949; 51: 660–672
  • Marullo S., Hoekeke J., Guillet J.-G., Strossberg A. D. Structural analysis of the epitope recognized by a monoclonal antibody directed against cyclic anti-depressant. J. Immunol. 1985; 135: 471–477
  • McAlpine S. B., Calabra J. J., Robinson M. D., Burke K. M., Jr. Late death and tricyclic anti-depressant overdose revisited. Ann. Emerg. Med. 1986; 15: 11
  • Rolline D. E., Brizgys H. Immunological Approach to Poisoning. Ann. Emerg. Med. 1986; 15: 9
  • Marcus L., Margel S., Savin H., Offarim M., Ravid M. Therapy of digoxin intoxicaton in dogs by specific hemoperfusion through agarose polyacrolein microsphere beads-antidigoxin antibodies. Amer. Heart. J. 1985; 110: 30–39

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.